Literature DB >> 669855

The effect in vivo of chemotherapeutic drug--antibody conjugates in two murine experimental tumor systems.

E Hurwitz, R Maron, A Bernstein, M Wilchek, M Sela, R Arnon.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 669855     DOI: 10.1002/ijc.2910210612

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  13 in total

Review 1.  Monoclonal antibodies. Future potential in cancer chemotherapy.

Authors:  C Kosmas; H Kalofonos; A A Epenetos
Journal:  Drugs       Date:  1989-11       Impact factor: 9.546

2.  My life with affinity.

Authors:  Meir Wilchek
Journal:  Protein Sci       Date:  2004-11       Impact factor: 6.725

3.  Inhibition of human tumor growth in nude mice by a conjugate of doxorubicin with monoclonal antibodies to epidermal growth factor receptor.

Authors:  E Aboud-Pirak; E Hurwitz; F Bellot; J Schlessinger; M Sela
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

Review 4.  Antibodies as specific carriers for chemotherapeutic agents.

Authors:  F H Lee; K M Hwang
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

5.  Immunotargeting of daunomycin to localized and metastatic human colon adenocarcinoma in athymic mice.

Authors:  E Hurwitz; R Adler; D Shouval; H Takahashi; J R Wands; M Sela
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

6.  Effects of methotrexate-carcinoembryonic-antigen-antibody immunoconjugates on GW-39 human tumors in nude mice.

Authors:  L B Shih; D M Goldenberg
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

7.  Preparation of AHTG-DNR conjugates and their antitumor effect in vitro.

Authors:  D H Zhang; J Z Tang; G X Shen; N Shu; H F Zhu
Journal:  J Tongji Med Univ       Date:  1990

8.  Selective killing of carcinoembryonic-antigen (CEA)-producing cells in vitro by the immunoconjugate cytorhodin-S and CEA-reactive cytorhodin-S antibody CA208.

Authors:  T Iwahashi; Y Tone; J Usui; H Watanabe; I Sugawara; S Mori; H Okazaki
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

9.  Chemotherapy by intravenous administration of conjugates of daunomycin with monoclonal and conventional anti-rat alpha-fetoprotein antibodies.

Authors:  Y Tsukada; E Hurwitz; R Kashi; M Sela; N Hibi; A Hara; H Hirai
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

10.  The effect of an anti-membrane antibody-methotrexate conjugate on the human prostatic tumour line PC3.

Authors:  A J Rowland; M E Harper; D W Wilson; K Griffiths
Journal:  Br J Cancer       Date:  1990-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.